Neogen Corp
In Vitro & In Vivo Diagnostic Substances · Lansing, MI, United States
- PrincipalsAmy M RocklinChief Legal OfficerDavid H. NaemuraChief Financial OfficerDouglas Edward JonesFormer COOand 15 more
- CompanyNeogen CorpLansing, MI, United States
- Phone line+1 (517) 372-9200General business
Neogen Corp is an SEC-registered Nasdaq-listed company (ticker NEOG) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions
People 18
Chair & board
Aashima GuptaDirector (Board)
Andrea F WainerDirector (Board)
Avi PelossofDirector (Board)
Catherine E WotekiDirector (Board)
Operations
Douglas Edward JonesFormer COO
Legal
Amy M RocklinChief Legal Officer
Everyone else on file (1)
Tamara A. RanalliSenior Vice President
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Amy M Rocklin — Chief Legal Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David H. Naemura — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Douglas Edward Jones — Former COO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗John Edward Adent — Former CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Xenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capability